 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 08/07/2018 |
$97.30 |
$98.35 |
$93.74 |
$94.06 |
8.89M | | 08/08/2018 |
$93.52 |
$94.08 |
$92.87 |
$93.73 |
4.54M | | 08/09/2018 |
$94.20 |
$96.14 |
$93.47 |
$95.47 |
6.11M | | 08/10/2018 |
$95.35 |
$96.74 |
$95.31 |
$95.80 |
4.45M | | 08/13/2018 |
$96.00 |
$97.58 |
$95.81 |
$96.78 |
5.87M |
|
|
| AbbVie is a research-based biopharmaceutical company. Co.'s portfolio of products includes a line of therapies that addresses serious diseases such as: HUMIRA (adalimumab) to treat autoimmune diseases; oncology products such as IMBRUVICA (ibrutinib) and Venclexta (venetoclax); virology products such as VIEKIRA PAK for the treatment of hepatitis C and Norvir (ritonavir) for the treatment of human immunodeficiency virus-1 infection; metabolic and hormone products that target conditions such as testosterone deficiency; endocrinology products such as Lupron (leuprolide acetate) for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty. | |
|
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on August 07, 2018, ABBV opened at $97.30, traded as high as $98.35 and as low as $93.74, and closed at $94.06. Trading volume was a total of 8.89M shares. On August 08, 2018, ABBV opened at $93.52, traded as high as $94.08 and as low as $92.87, and closed at $93.73. Trading volume was a total of 4.54M shares. On August 09, 2018, ABBV opened at $94.20, traded as high as $96.14 and as low as $93.47, and closed at $95.47. Trading volume was a total of 6.11M shares. On August 10, 2018, ABBV opened at $95.35, traded as high as $96.74 and as low as $95.31, and closed at $95.80. Trading volume was a total of 4.45M shares. On August 13, 2018, ABBV opened at $96.00, traded as high as $97.58 and as low as $95.81, and closed at $96.78. Trading volume was a total of 5.87M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
08/13/2018 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$96.78 |
|
| Starting shares: |
284.74 |
|
| Ending shares: |
349.91 |
|
| Dividends reinvested/share: |
$12.75 |
|
| Total return: |
238.64% |
|
| Average Annual Total Return: |
24.28% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$33,859.58 |
|
| Years: |
5.61 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
08/13/2018 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$96.78 |
|
| Dividends collected/share: |
$12.75 |
|
| Total return: |
211.87% |
|
| Average Annual Total Return: |
22.47% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$31,183.95 |
|
| Years: |
5.61 |
|
|
|
| Date |
Close |
| 08/07/2018 | $94.06 | | 08/08/2018 | $93.73 | | 08/09/2018 | $95.47 | | 08/10/2018 | $95.80 | | 08/13/2018 | $96.78 |
|
|
